This was reported by TASS with reference to the press service of the department.
"The Russian Ministry of Health approved the 12th version of the temporary guidelines for the prevention, diagnosis and treatment of new coronavirus infection (COVID-19), prepared by leading Russian experts, taking into account the accumulated scientific data," the ministry said.
It is clarified that the new version of the recommendations has updated the sections related to laboratory diagnosis of COVID-19, radiation diagnostics, sections that determine the tactics of treatment, including the management of pregnant women.
According to the press service, in particular, in the new recommendations, the drug Umifenovir was excluded from the treatment regimen for patients with coronavirus who have risk factors and a mild course of the disease.
Earlier, Andrei Tyazhelnikov, the chief specialist for primary health care for adults of the Moscow Department of Health, in an interview with the NSN, called for vaccinations in the context of a pandemic.